| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 7 3189-3194, Copyright © 1997 by American Association of Immunologists
ARTICLES |
MY Olsson-Alheim, M Salcedo, HG Ljunggren, K Karre and CL Sentman
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
NK cells from C57BL/6 (B6) mice and H-2Dd transgenic B6 (D8) mice express different levels of the inhibitory receptor Ly49A, and they also differ in their target cell specificity. Here, we examined this differential specificity with respect to the role of the Ly49A receptor expression on effector cells and levels of H-2Dd inhibitory ligands on target cells. NK cells from D8 mice express low levels of Ly49A receptor (Ly49Alow), and are able to kill SP2/0 tumor cells in spite of their expression of H-2Dd. H-2Dd is expressed at reduced levels on SP2/0 cells; when these were increased three- to fivefold after IFN- gamma treatment, the killing by Ly49Alow NK cells from D8 mice was markedly reduced. Efficient killing was restored when the effectors were preincubated with anti-Ly49A F(ab')2 Abs. A separate experimental system was based on D8 TAP1-deficient Con A blasts exogenously loaded with H-2Dd-specific peptides. In this system, higher levels of cell surface H-2Dd had to be induced by peptide to inhibit D8 Ly49Alow NK cells to an extent similar to that of B6 Ly49Ahigh NK cells. Ly49A receptors on NK cells from H-2Dd transgenic mice are thus functional, although they require high levels of ligand to inhibit progression of the NK-target cell interaction. The data are in favor of the "receptor- calibration" model, which suggests that down-regulation of inhibitory receptors on NK cells may be useful in order for NK cells to discriminate between normal and reduced levels of MHC class I molecules.
This article has been cited by other articles:
|
|
 |
|
  S. Cooley, F. Xiao, M. Pitt, M. Gleason, V. McCullar, T. L. Bergemann, K. L. McQueen, L. A. Guethlein, P. Parham, and J. S. Miller A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature Blood, July 15, 2007; 110(2): 578 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Bui, L. N. Carayannopoulos, L. L. Lanier, W. M. Yokoyama, and R. D. Schreiber IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors J. Immunol., January 15, 2006; 176(2): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koike, H. Wakao, Y. Ishizuka, T.-a. Sato, M. Hamaoki, K.-i. Seino, H. Koseki, T. Nakayama, and M. Taniguchi Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I J. Exp. Med., January 5, 2004; 199(1): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schott, R. Bonasio, and H. L. Ploegh Elimination In Vivo of Developing T Cells by Natural Killer Cells J. Exp. Med., October 20, 2003; 198(8): 1213 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zimmer, V. Ioannidis, and W. Held H-2D Ligand Expression by Ly49A+ Natural Killer (NK) Cells Precludes Ligand Uptake from Environmental Cells: Implications for NK Cell Function J. Exp. Med., November 19, 2001; 194(10): 1531 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Koh, B. R. Blazar, T. George, L. A. Welniak, C. M. Capitini, A. Raziuddin, W. J. Murphy, and M. Bennett Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo Blood, May 15, 2001; 97(10): 3132 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, K. Natarajan, L. F. Boyd, J. Tormo, R. A. Mariuzza, W. M. Yokoyama, and D. H. Margulies Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells J. Immunol., December 15, 2000; 165(12): 6922 - 6932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, J. Dorfman, D. Plaksin, K. Natarajan, I. M. Belyakov, R. Hunziker, J. A. Berzofsky, W. M. Yokoyama, M. G. Mage, and D. H. Margulies NK and CTL Recognition of a Single Chain H-2Dd Molecule: Distinct Sites of H-2Dd Interact with NK and TCR J. Immunol., October 1, 1999; 163(7): 3699 - 3708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Depatie, A. Chalifour, C. Pare, S.-H. Lee, S. M. Vidal, and S. Lemieux3 Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets Int. Immunol., September 1, 1999; 11(9): 1541 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Manilay, G. L. Waneck, and M. Sykes Levels of Ly-49 Receptor Expression Are Determined by the Frequency of Interactions with MHC Ligands: Evidence Against Receptor Calibration to a ""Useful"" Level J. Immunol., September 1, 1999; 163(5): 2628 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Andersson, S. Freland, M. H. Johansson, R. Wallin, J. K. Sandberg, B. J. Chambers, B. Christensson, U. Lendahl, S. Lemieux, M. Salcedo, et al. MHC Class I Mosaic Mice Reveal Insights into Control of Ly49C Inhibitory Receptor Expression in NK Cells J. Immunol., December 15, 1998; 161(12): 6475 - 6479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kase, M. H. Johansson, M. Y. Olsson-Alheim, K. Karre, and P. Hoglund External and Internal Calibration of the MHC Class I-Specific Receptor Ly49A on Murine Natural Killer Cells J. Immunol., December 1, 1998; 161(11): 6133 - 6138. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
